OTUD7B anticorps
Aperçu rapide pour OTUD7B anticorps (ABIN7117156)
Antigène
Voir toutes OTUD7B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- OTUD7B antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- OTU domain containing 7B
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- OTUD7B (OTU Domain Containing 7B (OTUD7B))
-
Autre désignation
- OTUD7B
-
Sujet
-
Synonyms: OTU domain-containing protein 7B|Cellular zinc finger anti-NF-kappa-B protein (Cezanne)|Zinc finger A20 domain-containing protein 1|Zinc finger protein Cezanne|OTUD7B|ZA20D1
Background: Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF-kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections. Mediates deubiquitination of EGFR. Has deubiquitinating activity toward 'Lys-11', 'Lys-48' or 'Lys-63'-linked polyubiquitin chains. In vitro, has preference for 'Lys-11'-linked polyubiquitin chains, however such data are unsure in vivo. Hydrolyzes both linear and branched forms of polyubiquitin.
-
Poids moléculaire
- 100 kDa
-
ID gène
- 56957
-
UniProt
- Q6GQQ9
Antigène
-